Key Patent Issued on Qantu's QT-0101 Adjuvant
25. Februar 2019 05:00 ET
|
QANTU Therapeutics, Inc.
LEWISVILLE, Texas, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Qantu Therapeutics, Inc. announces the issuance of United States patent 10,195,257 titled “Vaccine Formulations Comprising Quillaja...
Qantu Publishes Study Analyzing the Situation of Alzheimer's Disease Vaccines Development
20. April 2016 09:00 ET
|
QANTU Therapeutics, Inc.
LEWISVILLE, TX--(Marketwired - April 20, 2016) - Qantu Therapeutics, Inc. announces the publication of the article "A retrospective analysis of the Alzheimer's disease vaccine progress The...